(Q44644755)

5 December 2017

title

Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats (English)

1 reference

5 December 2017

1 reference

1 reference

8

1 reference

5 December 2017

9

1 reference

5 December 2017

author name string

Sijo Joseph Thandapilly

1

1 reference

5 December 2017

Xavier Lieben Louis

2

1 reference

5 December 2017

John Behbahani

3

1 reference

5 December 2017

Ali Movahed

4

1 reference

5 December 2017

Liping Yu

5

1 reference

5 December 2017

Robert Fandrich

6

1 reference

5 December 2017

Shetuan Zhang

7

1 reference

5 December 2017

Thomas Netticadan

10

1 reference

5 December 2017

publication date

20 June 2013

1 reference

5 December 2017

published in

Hypertension Research

1 reference

5 December 2017

volume

36

1 reference

5 December 2017

issue

10

1 reference

5 December 2017

page(s)

866-872

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2013.55

5 December 2017

exact match

0 references

cites work

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Cardiac hypertrophy and antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Resveratrol and health--a comprehensive review of human clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Cellular and molecular effects of resveratrol in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Effects of intravenous ABT-870 (iron (III)-hydroxide oligosaccharide) on mean arterial pressure and heart rate in the anaesthetized beagle: comparison with other iron-containing haematinic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating NO-AMPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Antihypertensive treatment improves endothelium-dependent hyperpolarization in the mesenteric artery of spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Pregnancy reverses hypertensive remodeling of cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Validation of volume-pressure recording tail-cuff blood pressure measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

A comparative serial echocardiographic analysis of cardiac structure and function in rats subjected to pressure or volume overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Morphology of the intestinal arterioles in chronic human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

In vitro perfusion studies of resistance artery function in genetic hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Treatment with low-dose resveratrol reverses cardiac impairment in obese prone but not in obese resistant rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Blood pressure-independent attenuation of cardiac hypertrophy by AT(1)R-AS gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Resveratrol and small artery compliance and remodeling in the spontaneously hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Oxidative Stress and Inflammation in Heart Disease: Do Antioxidants Have a Role in Treatment and/or Prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Resveratrol modulates interleukin-1β-induced phosphatidylinositol 3-kinase and nuclear factor κB signaling pathways in human tenocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

Temporal relation of cardiac hypertrophy, oxidative stress, and fatty acid metabolism in spontaneously hypertensive rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

7 January 2021

Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

7 January 2021

Resveratrol Arrests and Regresses the Development of Pressure Overload- but Not Volume Overload-Induced Cardiac Hypertrophy in Rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

7 January 2021

Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

7 January 2021

Effect of pressurization on mechanical properties of mesenteric small arteries from spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

7 January 2021

Mechanics and composition of human subcutaneous resistance arteries in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.55

7 January 2021

Identifiers

DOI

10.1038/HR.2013.55

1 reference

Dimensions Publication ID

5 December 2017

1033584801

0 references

1 reference